157 related articles for article (PubMed ID: 2834619)
1. Identification of D1-like dopamine receptors on human blood platelets.
De Keyser J; De Waele M; Convents A; Ebinger G; Vauquelin G
Life Sci; 1988; 42(18):1797-806. PubMed ID: 2834619
[TBL] [Abstract][Full Text] [Related]
2. Binding sites for [3H]SCH 23390 in retina: properties and possible relationship to dopamine D1-receptors mediating stimulation of adenylate cyclase.
Makman MH; Dvorkin B
Brain Res; 1986 Dec; 387(3):261-70. PubMed ID: 2950967
[TBL] [Abstract][Full Text] [Related]
3. Solubilization and reconstitution of dopamine D1 receptor from bovine striatal membranes: effects of agonist and antagonist pretreatment.
Srivastava LK; Ross GM; Bajwa SB; Mishra RK
Neurochem Res; 1990 Jun; 15(6):647-57. PubMed ID: 1977093
[TBL] [Abstract][Full Text] [Related]
4. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
5. Evidence for different states of the dopamine D1 receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase-coupled state of the D1 receptor.
Andersen PH; Braestrup C
J Neurochem; 1986 Dec; 47(6):1822-31. PubMed ID: 2945903
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D1 receptors characterized with [3H]SCH 23390. Solubilization of a guanine nucleotide-sensitive form of the receptor.
Niznik HB; Otsuka NY; Dumbrille-Ross A; Grigoriadis D; Tirpak A; Seeman P
J Biol Chem; 1986 Jun; 261(18):8397-406. PubMed ID: 3522568
[TBL] [Abstract][Full Text] [Related]
7. Agonist and antagonist interactions with D1 dopamine receptors: agonist-induced masking of D1 receptors depends on intrinsic activity.
O'Boyle KM; Waddington JL
Neuropharmacology; 1992 Feb; 31(2):177-83. PubMed ID: 1532443
[TBL] [Abstract][Full Text] [Related]
8. Opposing roles of dopamine D1 and D2 receptors in nigral gamma-[3H]aminobutyric acid release?
Starr M
J Neurochem; 1987 Oct; 49(4):1042-9. PubMed ID: 2957468
[TBL] [Abstract][Full Text] [Related]
9. Activation of the 5-HT1C receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393.
Briggs CA; Pollock NJ; Frail DE; Paxson CL; Rakowski RF; Kang CH; Kebabian JW
Br J Pharmacol; 1991 Dec; 104(4):1038-44. PubMed ID: 1687364
[TBL] [Abstract][Full Text] [Related]
10. Characterization of dopamine and beta-adrenergic receptors linked to cyclic AMP formation in intact cells of the clone D384 derived from a human astrocytoma.
Balmforth AJ; Yasunari K; Vaughan PF; Ball SG
J Neurochem; 1988 Nov; 51(5):1510-5. PubMed ID: 2459312
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.
Deveney AM; Waddington JL
Br J Pharmacol; 1995 Oct; 116(3):2120-6. PubMed ID: 8640354
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and functional evidence for the presence of dopamine D1 receptors in the bovine ciliary body.
Lograno MD; Daniele E; Govoni S
Exp Eye Res; 1990 Nov; 51(5):495-501. PubMed ID: 1979033
[TBL] [Abstract][Full Text] [Related]
13. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
14. Identification of D1-dopamine receptor in chicken embryo retina with [125I]SCH 23982.
Agui T; Chase TN; Kebabian JW
Brain Res; 1988 Jun; 452(1-2):49-56. PubMed ID: 2969765
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of the D1- and D2-like dopamine receptors from the brain of the leopard frog, Rana pipiens.
Chu J; Wilczynski W; Wilcox RE
Brain Behav Evol; 2001 Jun; 57(6):328-42. PubMed ID: 11713387
[TBL] [Abstract][Full Text] [Related]
16. Investigation of rat striatal dopamine D-1 receptors solubilized by digitonin with a precipitation method.
Zhang X; Segawa T
Eur J Pharmacol; 1989 Aug; 166(3):401-10. PubMed ID: 2680521
[TBL] [Abstract][Full Text] [Related]
17. The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors.
Andringa G; Drukarch B; Leysen JE; Cools AR; Stoof JC
Eur J Pharmacol; 1999 Jan; 364(1):33-41. PubMed ID: 9920182
[TBL] [Abstract][Full Text] [Related]
18. Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.
Van Vliet BJ; Mulder AH; Schoffelmeer AN
J Neurochem; 1990 Oct; 55(4):1274-80. PubMed ID: 2168934
[TBL] [Abstract][Full Text] [Related]
19. Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.
Urwyler S; Markstein R
J Neurochem; 1986 Apr; 46(4):1058-67. PubMed ID: 2936868
[TBL] [Abstract][Full Text] [Related]
20. Growth of cultured human cerebral meningiomas is inhibited by dopaminergic agents. Presence of high affinity dopamine-D1 receptors.
Schrell UM; Fahlbusch R; Adams EF; Nomikos P; Reif M
J Clin Endocrinol Metab; 1990 Dec; 71(6):1669-71. PubMed ID: 1699967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
